位置:首页 > 蛋白库 > AGRL4_HUMAN
AGRL4_HUMAN
ID   AGRL4_HUMAN             Reviewed;         690 AA.
AC   Q9HBW9; B1AR71; Q5KU34;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-NOV-2008, sequence version 3.
DT   03-AUG-2022, entry version 176.
DE   RecName: Full=Adhesion G protein-coupled receptor L4 {ECO:0000303|PubMed:25713288};
DE   AltName: Full=EGF, latrophilin and seven transmembrane domain-containing protein 1;
DE   AltName: Full=EGF-TM7-latrophilin-related protein;
DE            Short=ETL protein;
DE   Flags: Precursor;
GN   Name=ADGRL4 {ECO:0000303|PubMed:25713288}; Synonyms=ELTD1, ETL;
GN   ORFNames=UNQ202/PRO228;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLY-620.
RC   TISSUE=Bone marrow;
RA   Hirose M., Urakawa I., Yamano S., Okazaki H.;
RT   "Probable G-protein coupled receptor.";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-300.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-300.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 67-690, VARIANT LEU-300, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=11050079; DOI=10.1074/jbc.m004814200;
RA   Nechiporuk T., Urness L.D., Keating M.T.;
RT   "ETL, a novel seven-transmembrane receptor that is developmentally
RT   regulated in the heart.";
RL   J. Biol. Chem. 276:4150-4157(2001).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-249.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   SUBCELLULAR LOCATION, SUBUNIT, GLYCOSYLATION, INDUCTION, AND FUNCTION.
RX   PubMed=23871637; DOI=10.1016/j.ccr.2013.06.004;
RA   Masiero M., Simoes F.C., Han H.D., Snell C., Peterkin T., Bridges E.,
RA   Mangala L.S., Wu S.Y., Pradeep S., Li D., Han C., Dalton H.,
RA   Lopez-Berestein G., Tuynman J.B., Mortensen N., Li J.L., Patient R.,
RA   Sood A.K., Banham A.H., Harris A.L., Buffa F.M.;
RT   "A core human primary tumor angiogenesis signature identifies the
RT   endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.";
RL   Cancer Cell 24:229-241(2013).
RN   [9]
RP   NOMENCLATURE.
RX   PubMed=25713288; DOI=10.1124/pr.114.009647;
RA   Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R.,
RA   Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A., Liebscher I.,
RA   Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C., Piao X., Promel S.,
RA   Schoneberg T., Schwartz T.W., Singer K., Stacey M., Ushkaryov Y.A.,
RA   Vallon M., Wolfrum U., Wright M.W., Xu L., Langenhan T., Schioth H.B.;
RT   "International union of basic and clinical pharmacology. XCIV. Adhesion G
RT   protein-coupled receptors.";
RL   Pharmacol. Rev. 67:338-367(2015).
CC   -!- FUNCTION: Endothelial orphan receptor that acts as a key regulator of
CC       angiogenesis. {ECO:0000269|PubMed:23871637}.
CC   -!- SUBUNIT: Heterodimer of 2 chains generated by proteolytic processing;
CC       the large extracellular N-terminal fragment and the membrane-bound C-
CC       terminal fragment predominantly remain associated and non-covalently
CC       linked. {ECO:0000250|UniProtKB:Q9ESC1, ECO:0000269|PubMed:23871637}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23871637};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Detected in the majority of epithelial cells in
CC       tumor and normal tissues. Expressed also in human umbilical vein
CC       endothelial cells. {ECO:0000269|PubMed:23871637}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated in the adult heart.
CC       {ECO:0000269|PubMed:11050079}.
CC   -!- INDUCTION: Up-regulated in tumor endothelial cells. Up-regulated by
CC       DLL4. {ECO:0000269|PubMed:23871637}.
CC   -!- DOMAIN: The transmembrane domain is not required for cleavage, but it
CC       is required for dimer formation. {ECO:0000250|UniProtKB:Q9ESC1}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:23871637}.
CC   -!- PTM: Proteolytically cleaved into 2 subunits, an extracellular alpha
CC       subunit and a seven-transmembrane subunit.
CC       {ECO:0000250|UniProtKB:Q9ESC1}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       Adhesion G-protein coupled receptor (ADGR) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG33021.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH25721.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB032017; BAD83584.1; -; mRNA.
DR   EMBL; AY358360; AAQ88726.1; -; mRNA.
DR   EMBL; AC098651; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099674; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596269; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06345.1; -; Genomic_DNA.
DR   EMBL; BC025721; AAH25721.1; ALT_INIT; mRNA.
DR   EMBL; AF192403; AAG33021.1; ALT_INIT; mRNA.
DR   CCDS; CCDS41352.1; -.
DR   RefSeq; NP_071442.2; NM_022159.3.
DR   AlphaFoldDB; Q9HBW9; -.
DR   SMR; Q9HBW9; -.
DR   BioGRID; 122076; 2.
DR   IntAct; Q9HBW9; 1.
DR   STRING; 9606.ENSP00000359778; -.
DR   ChEMBL; CHEMBL4523920; -.
DR   MEROPS; P02.013; -.
DR   TCDB; 9.A.14.6.3; the g-protein-coupled receptor (gpcr) family.
DR   GlyConnect; 1915; 15 N-Linked glycans (4 sites).
DR   GlyGen; Q9HBW9; 10 sites, 15 N-linked glycans (4 sites).
DR   iPTMnet; Q9HBW9; -.
DR   PhosphoSitePlus; Q9HBW9; -.
DR   BioMuta; ADGRL4; -.
DR   DMDM; 212276505; -.
DR   EPD; Q9HBW9; -.
DR   MassIVE; Q9HBW9; -.
DR   PaxDb; Q9HBW9; -.
DR   PeptideAtlas; Q9HBW9; -.
DR   PRIDE; Q9HBW9; -.
DR   ProteomicsDB; 81602; -.
DR   ABCD; Q9HBW9; 1 sequenced antibody.
DR   Antibodypedia; 9366; 226 antibodies from 30 providers.
DR   DNASU; 64123; -.
DR   Ensembl; ENST00000370742.4; ENSP00000359778.3; ENSG00000162618.15.
DR   GeneID; 64123; -.
DR   KEGG; hsa:64123; -.
DR   MANE-Select; ENST00000370742.4; ENSP00000359778.3; NM_022159.4; NP_071442.2.
DR   UCSC; uc001diq.5; human.
DR   CTD; 64123; -.
DR   DisGeNET; 64123; -.
DR   GeneCards; ADGRL4; -.
DR   HGNC; HGNC:20822; ADGRL4.
DR   HPA; ENSG00000162618; Tissue enhanced (adipose).
DR   MIM; 616419; gene.
DR   neXtProt; NX_Q9HBW9; -.
DR   OpenTargets; ENSG00000162618; -.
DR   PharmGKB; PA134946418; -.
DR   VEuPathDB; HostDB:ENSG00000162618; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; KOG4193; Eukaryota.
DR   GeneTree; ENSGT00940000158252; -.
DR   HOGENOM; CLU_002753_3_8_1; -.
DR   InParanoid; Q9HBW9; -.
DR   OMA; SKMKHIH; -.
DR   OrthoDB; 388923at2759; -.
DR   PhylomeDB; Q9HBW9; -.
DR   TreeFam; TF316380; -.
DR   PathwayCommons; Q9HBW9; -.
DR   SignaLink; Q9HBW9; -.
DR   BioGRID-ORCS; 64123; 10 hits in 1071 CRISPR screens.
DR   GeneWiki; ELTD1; -.
DR   GenomeRNAi; 64123; -.
DR   Pharos; Q9HBW9; Tbio.
DR   PRO; PR:Q9HBW9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9HBW9; protein.
DR   Bgee; ENSG00000162618; Expressed in pericardium and 186 other tissues.
DR   ExpressionAtlas; Q9HBW9; baseline and differential.
DR   Genevisible; Q9HBW9; HS.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:GDB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:GDB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IEA:Ensembl.
DR   Gene3D; 2.60.220.50; -; 1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR032471; GAIN_dom_N.
DR   InterPro; IPR046338; GAIN_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF16489; GAIN; 1.
DR   Pfam; PF01825; GPS; 1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00181; EGF; 2.
DR   SMART; SM00179; EGF_CA; 1.
DR   SMART; SM00303; GPS; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GPS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Disulfide bond; EGF-like domain;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Repeat; Signal; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..690
FT                   /note="Adhesion G protein-coupled receptor L4"
FT                   /id="PRO_0000012870"
FT   TOPO_DOM        20..432
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        433..453
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        454..460
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        461..481
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        482..499
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        500..520
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        521..532
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        533..553
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        554..573
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        574..594
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        595..618
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        619..639
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        640..646
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        647..667
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        668..690
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          20..57
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          58..108
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          367..418
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   SITE            406..407
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ESC1"
FT   CARBOHYD        21
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        64
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        381
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        395
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        22..33
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        27..42
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        44..56
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        62..75
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        69..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        86..107
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   VARIANT         300
FT                   /note="V -> L (in dbSNP:rs12754818)"
FT                   /evidence="ECO:0000269|PubMed:11050079,
FT                   ECO:0000269|PubMed:12975309, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_047072"
FT   VARIANT         599
FT                   /note="H -> Q (in dbSNP:rs1968956)"
FT                   /id="VAR_047073"
FT   VARIANT         620
FT                   /note="A -> G (in dbSNP:rs2275902)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_047074"
SQ   SEQUENCE   690 AA;  77811 MW;  38BFEEBCEADDEFC8 CRC64;
     MKRLPLLVVF STLLNCSYTQ NCTKTPCLPN AKCEIRNGIE ACYCNMGFSG NGVTICEDDN
     ECGNLTQSCG ENANCTNTEG SYYCMCVPGF RSSSNQDRFI TNDGTVCIEN VNANCHLDNV
     CIAANINKTL TKIRSIKEPV ALLQEVYRNS VTDLSPTDII TYIEILAESS SLLGYKNNTI
     SAKDTLSNST LTEFVKTVNN FVQRDTFVVW DKLSVNHRRT HLTKLMHTVE QATLRISQSF
     QKTTEFDTNS TDIALKVFFF DSYNMKHIHP HMNMDGDYIN IFPKRKAAYD SNGNVAVAFV
     YYKSIGPLLS SSDNFLLKPQ NYDNSEEEER VISSVISVSM SSNPPTLYEL EKITFTLSHR
     KVTDRYRSLC AFWNYSPDTM NGSWSSEGCE LTYSNETHTS CRCNHLTHFA ILMSSGPSIG
     IKDYNILTRI TQLGIIISLI CLAICIFTFW FFSEIQSTRT TIHKNLCCSL FLAELVFLVG
     INTNTNKLFC SIIAGLLHYF FLAAFAWMCI EGIHLYLIVV GVIYNKGFLH KNFYIFGYLS
     PAVVVGFSAA LGYRYYGTTK VCWLSTENNF IWSFIGPACL IILVNLLAFG VIIYKVFRHT
     AGLKPEVSCF ENIRSCARGA LALLFLLGTT WIFGVLHVVH ASVVTAYLFT VSNAFQGMFI
     FLFLCVLSRK IQEEYYRLFK NVPCCFGCLR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024